PHARMACEUTICAL COMPOSITION FOR ADENOVIRAL CONJUNCTIVITIS

摘要

The purpose of the present invention is to provide a pharmaceutical composition effective for adenoviral conjunctivitis.　Provided is a pharmaceutical composition for adenoviral conjunctivitis, containing an anti-adenovirus polyclonal antibody. The pharmaceutical composition is an ophthalmic solution. The pharmaceutical composition can be used for the treatment of adenoviral conjunctivitis. The pharmaceutical composition can be used for the prevention of adenoviral conjunctivitis in an uninfected eye.